| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.7% | 0.0% |
| Div Cover | 4.6 | 4.7 |
| Op Mrgn | 20.2% | 22.4% |
| ROCE | 52.9% |
| Latest | F'cast | |
|---|---|---|
| P/E | 31.3 | 34.3 |
| PEG | 1.5 | 3.5 |
| Pr/Revenue | 5.3 | 5.7 |
| Pr/Book | 6.3 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 1052.3% | 12.2% |
| PBT | 27.7% | 32.1% |
| EPS | 21.0% | 11.6% |
| DPS | 7.0% | 10.2% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-22 | 1,525.30 | 304.40 | 65.48p | 38.3 | 3.2 | +12% | 18.88p | 0.8% |
| 31-Mar-23 | 1,852.80 | 291.50 | 76.34p | 29.2 | 1.7 | +17% | 20.20p | 0.9% |
| 31-Mar-24 | 2,034.10 | 340.30 | 82.40p | 28.7 | 3.6 | +8% | 21.61p | 0.9% |
| 31-Mar-25 | 224.10 | 384.30 | 94.23p | 27.4 | 2.0 | +14% | 23.12p | 0.9% |
| 31-Mar-26 | 2,582.30 | 490.70 | 114.05p | 33.3 | 1.6 | +21% | 24.74p | 0.7% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Mar-27 | 2,898.21 | 648.18 | 127.24p | 28.4 | 2.5 | +12% | 27.27p | 0.0% |
| 31-Mar-28 | 3,148.13 | 708.15 | 140.44p | 25.7 | 2.5 | +10% | 29.70p | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Director/PDMR Shareholding | 10-Aug-2026 | 11:00 | RNS |
| Disposal | 04-Aug-2026 | 07:00 | RNS |
| Director/PDMR Shareholding | 24-Jul-2026 | 14:30 | RNS |
| Director dealings: Halma CEO makes share sale | 10-Aug-2026 | ShareCast |
| Halma buys Dreampath for up to €275m | 07-Jul-2026 | ShareCast |
| Halma adds to medical portfolio with two acquisi... | 02-Jul-2026 | ShareCast |
| BNS board increase holding in bid to boost share... | 26-Mar-2006 | Scotland on Sunday |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 07-Aug-26 | Sell | Marc Ronchetti | 3,812.84p | 47,000 | £1,792,034.03 |
| 23-Jul-26 | Sell | Jennifer Ward | 3,645.07p | 13,145 | £479,143.88 |
| 22-Jul-26 | Sell | Jennifer Ward | 3,640.54p | 2,248 | £81,839.41 |
| Currency | UK Pounds |
| Share Price | 3,672.00p |
| Change Today | 56.00p |
| % Change | 1.55 % |
| 52 Week High | 4,878.00p |
| 52 Week Low | 3,218.00p |
| Volume | 167,272 |
| Shares Issued | 379.65m |
| Market Cap | £13,941m |
| RiskGrade | 112 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 4 |
| Buy | 3 |
| Neutral | 9 |
| Sell | 0 |
| Strong Sell | 1 |
| Total | 17 |

| Latest | Previous | |
|---|---|---|
| Final | Interim | |
| Ex-Div | 09-Jul-26 | 18-Dec-25 |
| Paid | 14-Aug-26 | 30-Jan-26 |
| Amount | 15.11p | 9.63p |
| Time | Volume / Share Price |
| 14:28 | 68 @ 3,672.00p |
| 14:27 | 156 @ 3,674.00p |
| 14:27 | 123 @ 3,674.00p |
| 14:27 | 322 @ 3,674.00p |
| 14:27 | 200 @ 3,674.00p |
| CFO | Carole Cran |
| CEO | Marc Ronchetti |
| Chair | Dame Louise Makin |
You are here: research